Jun 13, 2023 / 10:20PM GMT
Madhu Sudhan Kumar - Goldman Sachs Group, Inc., Research Division - Research Analyst
All right. Thanks, everyone, for joining us here at the Goldman Sachs Global Healthcare Conference. We're so thrilled to be joined by the team from Jazz. Obviously, at a really interesting crossroads for the company. So really a perfect time to get in front of the company, hear what's going on and where things are headed. So Bruce, if you have a few opening remarks, we'll just dive right in.
Bruce C. Cozadd - Jazz Pharmaceuticals plc - Co-Founder, Chairman & CEO
Yes. So happy to be here. Thanks for your time. Let me introduce the team up here with me. Kim Sablich heads our U.S. commercialization business. Kelvin Tan is our Chief Medical Officer, and hopefully, will have interesting things to say, per your instructions. I will point out that we may make forward-looking statements today. If so, please see our SEC filings for risk factors. If we refer to non-GAAP numbers, there's always a full reconciliation on our website. And what else did I want to say, something else that I
Jazz Pharmaceuticals PLC at Goldman Sachs Healthcare Conference Transcript
Feb 07, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers